SAI LIFE SCIENCES
|
|
| BOM : 544306     NSE : SAILIFE     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Jun 12,2026 |
|
Price(EOD): ₹ 1,218.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 25,852.87 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SAI LIFE SCIENCES | 2.1% | 12.2% | 60.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | -0.9% | 6.8% |
| DIVIS LABORATORIES | 1.8% | -2.3% | 1.5% |
| TORRENT PHARMACEUTICALS | 3.7% | 6.5% | 44.9% |
| CIPLA | 0% | 4.7% | -8% |
| DR REDDYS LABORATORIES | -0.2% | 0.7% | -3.4% |
| MANKIND PHARMA | 0.9% | -1.2% | 0.8% |
| LUPIN | 1.8% | 3.5% | 13.8% |
| ZYDUS LIFESCIENCES | 1.6% | 17.6% | 15.2% |
FUNDAMENTAL ANALYSIS OF SAI LIFE SCIENCES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SAI LIFE SCIENCES
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
74.1
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 348.91 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 10.41
P/B Calculated based on Book Value of Rs 2,483.69 Cr
[Latest Year - Mar2026 - Consolidated Results ] 11.79
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,192.49 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
1154% 1072% -3% |
SHARE PRICE MOMENTUM OF SAI LIFE SCIENCES
SAI LIFE SCIENCES vs SENSEX
DEBT OF SAI LIFE SCIENCES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.06 0.71 0.77 0.51 |
0.06 0.74 0.8 0.53 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF SAI LIFE SCIENCES
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF SAI LIFE SCIENCES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
8.21% -6.02% 3.77% 3.85% |
3.91% 12.04% 17.2% 18.09% |
| QtrlyTrend |
6 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
SAI LIFE SCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 1% | 2.9% | 10.1% |
| BSE IPO | 0.9% | 4.2% | 12.2% |
| BSE 1000 | 0.6% | 1.5% | -1.6% |
| BSE 500 | 0.6% | 1.3% | -1.8% |
| BSE 250 SMALLCAP INDEX | 0.2% | 1.8% | -0.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 HEALTHCARE INDEX | 0.9% | 2.6% | NA |
| NIFTY SMALLCAP 50 | 0.8% | 1.8% | 1.6% |
| NIFTY 500 | 0.6% | 1.3% | -1.5% |
| NIFTY TOTAL MARKET | 0.6% | 1.5% | -1.3% |
| NIFTY MIDSMALL HEALTHCARE | 0.5% | 2.1% | 15.5% |
You may also like the below Video Courses
FAQ about SAI LIFE SCIENCES
Is SAI LIFE SCIENCES good for long term investment?
As on Jun 12,2026, the Fundamentals of SAI LIFE SCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of SAI LIFE SCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SAI LIFE SCIENCES UnderValued or OverValued?
As on Jun 12,2026, SAI LIFE SCIENCES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SAI LIFE SCIENCES ?
As on Jun 12,2026, the Intrinsic Value of SAI LIFE SCIENCES is Rs. 104.04 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 97.20
Fair Value [Median EV / Sales Model] : Rs. 104.04
Fair Value [Median Price / Sales Model] : Rs. 1,253.18
Estimated Median Fair Value of SAI LIFE SCIENCES : Rs. 104.04
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.